Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (701-710 of 749) with videos related to

Pageof 75
Sort By:
Journal for Immunotherapy of Cancer|December 1, 2023
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinomaMatthew H G Katz, Gina R Petroni, Todd Bauer, et al.
Journal of the National Cancer Institute|July 1, 2026
A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional studyCecilia G Ethun, Colin M Court, Joanne F Chou, et al.
JAMA Surgery|June 9, 2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101Matthew H G Katz, Qian Shi, Syed A Ahmad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium StudyEsther N Dekker, Jacob L van Dam, Quisette P Janssen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
The Journal of Surgical Research|April 8, 2022
Adolescent Vaping-Associated Trauma in the Western United StatesKatie W Russell, Micah G Katz, Ryan C Phillips, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Frontiers in Medicine|August 19, 2021
Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing WeightingDario Monzani, Serena Petrocchi, Serena Oliveri, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Pageof 75

Showing results (701-710 of 749) with videos related to

Sort By:
Pageof 75
Journal for Immunotherapy of Cancer|December 1, 2023
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinomaMatthew H G Katz, Gina R Petroni, Todd Bauer, et al.
Journal of the National Cancer Institute|July 1, 2026
A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional studyCecilia G Ethun, Colin M Court, Joanne F Chou, et al.
JAMA Surgery|June 9, 2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101Matthew H G Katz, Qian Shi, Syed A Ahmad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium StudyEsther N Dekker, Jacob L van Dam, Quisette P Janssen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
The Journal of Surgical Research|April 8, 2022
Adolescent Vaping-Associated Trauma in the Western United StatesKatie W Russell, Micah G Katz, Ryan C Phillips, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Frontiers in Medicine|August 19, 2021
Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing WeightingDario Monzani, Serena Petrocchi, Serena Oliveri, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Pageof 75